HCV Genotype 3
Showing 1 - 25 of >10,000
Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)
Chronic Hepatitis C Virus Infection Trial (OBV/PTV/r, Sofosbuvir, Ribavirin (RBV))
Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)
Not yet recruiting
- Hepatitis C
- Cirrhosis
- Sofosbuvir/Velpatasvir + Ribavirin
- Sofosbuvir/Velpatasvir/Voxilaprevir
- (no location specified)
Jul 20, 2022
Chronic Hepatitis C Virus Infection Trial in China, Korea, Republic of, Taiwan (P1101 + Ribavirin, PEG-Intron + Ribavirin)
Completed
- Chronic Hepatitis C Virus Infection
- P1101 + Ribavirin
- PEG-Intron + Ribavirin
-
Beijing, China
- +38 more
Jan 14, 2022
Chronic Hepatitis Trial in Italy (Peginterferon alpha-2a + Ribavirin)
Completed
- Chronic Hepatitis
- Peginterferon alpha-2a + Ribavirin
-
Avellino, Italy
- +34 more
Mar 9, 2022
Zepatier in Patients With Substance Use
Active, not recruiting
- Hepatitis C
- +3 more
- Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
-
Chicago, IllinoisUniversity of Illinois at Chicago
Jun 28, 2022
Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
Jul 9, 2021
Hepatitis C Trial in Seoul
Completed
- Hepatitis C
-
Seoul, Korea, Republic ofLocal Institution
Jan 6, 2022
Hepatitis C, Chronic Trial in Taiwan (P1101 + Ribavirin)
Recruiting
- Hepatitis C, Chronic
- P1101 + Ribavirin
-
Chiayi City, Taiwan
- +7 more
Jun 30, 2022
Hepatitis C Trial in Rotterdam (Peginterferon alfa-2a, Interferon alfa-2a, Ribavirin)
Completed
- Hepatitis C
- Peginterferon alfa-2a
- +2 more
-
Rotterdam, NetherlandsErasmus Medical Center
Aug 26, 2021
Chronic Hepatitis C Virus (HCV) Infection Trial (ABT-493/ABT-530, Placebo for ABT-493/ABT-530)
Completed
- Chronic Hepatitis C Virus (HCV) Infection
- ABT-493/ABT-530
- Placebo for ABT-493/ABT-530
- (no location specified)
Jul 14, 2021
Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir)
Completed
- Chronic Hepatitis C Infection
- Compensated Cirrhosis
- (no location specified)
Jul 8, 2021
Sickle Cell Disease Trial (Exa-cel)
Not yet recruiting
- Sickle Cell Disease
- Exa-cel
- (no location specified)
Jul 14, 2023
Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))
Completed
- Chronic Hepatitis C Virus (HCV) Infection Genotype 1
- ABT-450/r/ABT-267
- +2 more
-
Phoenix, Arizona
- +47 more
Jun 27, 2022
Hepatitis C Trial in Denver (Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV))
Terminated
- Hepatitis C
- Simeprivir (SMV)
- +2 more
-
Denver, ColoradoUniversity of Colorado Denver (Leprino Building)
Aug 16, 2021
Hepatitis C Virus Trial (ABT-450/r/ABT-267, Ribavirin)
Completed
- Hepatitis C Virus
- (no location specified)
Jul 28, 2021
Hepatitis C Infection, Hepatitis C Virus Trial (ombitasvir/paritaprevir/ritonavir, dasabuvir)
Completed
- Hepatitis C Infection
- Hepatitis C Virus
- (no location specified)
Jul 28, 2021
CYP3A4*22 Trial (Palbociclib 125Mg Tab, Ribociclib 200Mg Oral Tablet, Abemaciclib 150 MG Oral Tablet)
Not yet recruiting
- CYP3A4*22
- Palbociclib 125Mg Tab
- +2 more
- (no location specified)
Jan 10, 2023
Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis Trial (ABT-493, ABT-530, ABT-450/r/ABT-267, ABT-333)
Chronic Hepatics C Virus (HCV) Genotype 1, Non-Cirrhotic, Cirrhosis Trial in Beijing (TG-2349, DAG181, Ribavirin)
Completed
- Chronic Hepatics C Virus (HCV) Genotype 1
- +3 more
- TG-2349
- +2 more
-
Beijing, ChinaBeijing Tsinghua Changgung Hospital
Feb 2, 2021
Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))
Completed
- Chronic Hepatitis C Infection
- Compensated Cirrhosis
- ABT-450/r/ABT-267, ABT-333
- Ribavirin (RBV)
- (no location specified)
Jul 8, 2021